Is TECX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for TECX. It does not provide personalized investment advice.

TECX (Tectonic Therapeutic, Inc. Common Stock) Stock Analysis - Financials

Tectonic Therapeutic, Inc. Common Stock (TECX) is a publicly traded Healthcare sector company. As of September 21, 2026, TECX trades at $26.98 with a market cap of $527.83M and a P/E ratio of -5.90. TECX moved -0.94% today. Year to date, TECX is +29.43%; over the trailing twelve months it is +72.63%. Its 52-week range spans $13.70 to $61.07. Analyst consensus is strong buy with an average price target of $78.67. Rallies surfaces TECX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are TECX's key financials?

TECX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. TECX recently traded at $26.98. Market cap is $527.83M. P/E ratio is -5.90. Revenue is $-129.69M.

TECX Key Metrics

Key financial metrics for TECX
Metric	Value
Price	$26.98
Market Cap	$527.83M
P/E Ratio	-5.90
EPS	$-4.57
Dividend Yield	0.00%
52-Week High	$61.07
52-Week Low	$13.70
Volume	178.84K
Avg Volume	0
Revenue (TTM)	$-129.69M
Net Income	$-85.79M
Gross Margin	0.00%

TECX Analyst Consensus

6 analysts cover TECX: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $78.67.

Common questions about TECX

What are TECX's key financials?: TECX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. TECX recently traded at $26.98. Market cap is $527.83M. P/E ratio is -5.90. Revenue is $-129.69M.
Is TECX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for TECX. It does not provide personalized investment advice.